• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酒精性肝细胞脂肪变性。

Alcohol-induced steatosis in liver cells.

作者信息

Donohue Terrence M

机构信息

Liver Study Unit, Research Service (151), VA Medical Center, 4101 Woolworth Ave, Omaha, NE 68105, USA.

出版信息

World J Gastroenterol. 2007 Oct 7;13(37):4974-8. doi: 10.3748/wjg.v13.i37.4974.

DOI:10.3748/wjg.v13.i37.4974
PMID:17854140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4434621/
Abstract

Alcohol-induced fatty liver (steatosis) was believed to result from excessive generation of reducing equivalents from ethanol metabolism, thereby enhancing fat accumulation. Recent findings have revealed a more complex picture in which ethanol oxidation is still required, but specific transcription as well as humoral factors also have important roles. Transcription factors involved include the sterol regulatory element binding protein 1 (SREBP-1) which is activated to induce genes that regulate lipid biosynthesis. Conversely, ethanol consumption causes a general down-regulation of lipid (fatty acid) oxidation, a reflection of inactivation of the peroxisome proliferator-activated receptor-alpha (PPAR-alpha) that regulates genes involved in fatty acid oxidation. A third transcription factor is the early growth response-1 (Egr-1), which is strongly induced prior to the onset of steatosis. The activities of all these factors are governed by that of the principal regulatory enzyme, AMP kinase. Important humoral factors, including adiponectin, and tumor necrosis factor-alpha (TNF-alpha), also regulate alcohol-induced steatosis. Their levels are affected by alcohol consumption and by each other. This review will summarize the actions of these proteins in ethanol-elicited fatty liver. Because steatosis is now regarded as a significant risk factor for advanced liver pathology, an understanding of the molecular mechanisms in its etiology is essential for development of effective therapies.

摘要

酒精性脂肪肝(脂肪变性)被认为是乙醇代谢过程中还原当量过度生成所致,从而加剧脂肪堆积。最近的研究结果揭示了一幅更为复杂的图景,其中乙醇氧化仍然是必需的,但特定的转录以及体液因子也起着重要作用。涉及的转录因子包括固醇调节元件结合蛋白1(SREBP-1),其被激活以诱导调节脂质生物合成的基因。相反,乙醇摄入会导致脂质(脂肪酸)氧化普遍下调,这反映了过氧化物酶体增殖物激活受体α(PPAR-α)的失活,PPAR-α调节参与脂肪酸氧化的基因。第三个转录因子是早期生长反应因子1(Egr-1),它在脂肪变性发作之前被强烈诱导。所有这些因子的活性都受主要调节酶AMP激酶的活性控制。重要的体液因子,包括脂联素和肿瘤坏死因子-α(TNF-α),也调节酒精性脂肪变性。它们的水平受酒精摄入以及彼此的影响。本综述将总结这些蛋白质在乙醇诱发的脂肪肝中的作用。由于脂肪变性现在被视为晚期肝脏病变的重要危险因素,因此了解其病因中的分子机制对于开发有效的治疗方法至关重要。

相似文献

1
Alcohol-induced steatosis in liver cells.酒精性肝细胞脂肪变性。
World J Gastroenterol. 2007 Oct 7;13(37):4974-8. doi: 10.3748/wjg.v13.i37.4974.
2
Cellular steatosis in ethanol oxidizing-HepG2 cells is partially controlled by the transcription factor, early growth response-1.乙醇氧化-HepG2 细胞中的细胞脂肪变性部分受转录因子早期生长反应-1 的控制。
Int J Biochem Cell Biol. 2013 Feb;45(2):454-63. doi: 10.1016/j.biocel.2012.10.002. Epub 2012 Oct 24.
3
Dietary α-lactalbumin induced fatty liver by enhancing nuclear liver X receptor αβ/sterol regulatory element-binding protein-1c/PPARγ expression and minimising PPARα/carnitine palmitoyltransferase-1 expression and AMP-activated protein kinase α phosphorylation associated with atherogenic dyslipidaemia, insulin resistance and oxidative stress in Balb/c mice.膳食α-乳白蛋白通过增强核肝X受体αβ/固醇调节元件结合蛋白-1c/过氧化物酶体增殖物激活受体γ的表达,并使过氧化物酶体增殖物激活受体α/肉碱棕榈酰转移酶-1的表达以及与动脉粥样硬化性血脂异常、胰岛素抵抗和氧化应激相关的AMP激活蛋白激酶α磷酸化降至最低,从而在Balb/c小鼠中诱发脂肪肝。
Br J Nutr. 2017 Dec;118(11):914-929. doi: 10.1017/S000711451700232X. Epub 2017 Nov 27.
4
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.虾青素和安卡黄素作为天然 AMPK 激活剂,具有 PPARα 激动剂活性,可下调高脂饮食喂养的 C57BL/6 小鼠的非酒精性脂肪性肝炎。
Food Chem Toxicol. 2014 Feb;64:94-103. doi: 10.1016/j.fct.2013.11.015. Epub 2013 Nov 22.
5
Ethanol and liver: recent advances in the mechanisms of ethanol-induced hepatosteatosis.乙醇与肝脏:乙醇诱导肝脂肪变性机制的最新进展。
Arch Toxicol. 2009 Dec;83(12):1075-81. doi: 10.1007/s00204-009-0457-4.
6
TNF-alpha induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c).肿瘤坏死因子-α通过增强固醇调节元件结合蛋白-1c(SREBP-1c)的基因表达诱导小鼠肝脏脂肪变性。
Exp Biol Med (Maywood). 2007 May;232(5):614-21.
7
Alcohol and lipid metabolism.酒精与脂质代谢
J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S56-60. doi: 10.1111/j.1440-1746.2006.04582.x.
8
Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.药理学神经酰胺减少可缓解脂联素敲除小鼠的酒精性脂肪变性和肝肿大。
Am J Physiol Gastrointest Liver Physiol. 2014 Jun 1;306(11):G959-73. doi: 10.1152/ajpgi.00395.2013. Epub 2014 Apr 17.
9
Aqueous Extract of Pepino ( Ait) Leaves Ameliorate Lipid Accumulation and Oxidative Stress in Alcoholic Fatty Liver Disease.佩普诺(Ait)叶水提物改善酒精性脂肪肝疾病中的脂质积累和氧化应激。
Nutrients. 2018 Jul 20;10(7):931. doi: 10.3390/nu10070931.
10
Delayed ethanol elimination and enhanced susceptibility to ethanol-induced hepatosteatosis after liver resection.肝切除术后乙醇清除延迟及对乙醇诱导的肝脂肪变性易感性增加。
World J Gastroenterol. 2014 Dec 28;20(48):18249-59. doi: 10.3748/wjg.v20.i48.18249.

引用本文的文献

1
Pathogenesis of Alcohol-Associated Liver Disease.酒精相关性肝病的发病机制。
Clin Liver Dis. 2024 Nov;28(4):647-661. doi: 10.1016/j.cld.2024.06.005. Epub 2024 Jul 23.
2
TET2 regulation of alcoholic fatty liver via mRNA in paraspeckles.TET2通过副斑点中的mRNA对酒精性脂肪肝的调控
iScience. 2024 Feb 20;27(3):109278. doi: 10.1016/j.isci.2024.109278. eCollection 2024 Mar 15.
3
Anti-miR-873-5p improves alcohol-related liver disease by enhancing hepatic deacetylation via SIRT1.抗 miR-873-5p 通过 SIRT1 增强肝脏去乙酰化作用来改善酒精性肝病。
JHEP Rep. 2023 Sep 30;6(1):100918. doi: 10.1016/j.jhepr.2023.100918. eCollection 2024 Jan.
4
Establishment of a Rat Model of Alcoholic Liver Fibrosis with Simulated Human Drinking Patterns and Low-Dose Chemical Stimulation.建立具有模拟人类饮酒模式和低剂量化学刺激的酒精性肝纤维化大鼠模型。
Biomolecules. 2023 Aug 24;13(9):1293. doi: 10.3390/biom13091293.
5
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options.肝细胞癌概述:从分子角度到未来的治疗选择。
Cell Adh Migr. 2023 Dec;17(1):1-21. doi: 10.1080/19336918.2023.2258539. Epub 2023 Sep 19.
6
The Role of Endoplasmic Reticulum Stress Response in Liver Regeneration.内质网应激反应在肝脏再生中的作用。
Semin Liver Dis. 2023 Aug;43(3):279-292. doi: 10.1055/a-2129-8977. Epub 2023 Jul 14.
7
The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma.mTOR 抑制剂在肝癌肝移植术后的作用。
Curr Oncol. 2023 Jun 9;30(6):5574-5592. doi: 10.3390/curroncol30060421.
8
Non-Invasive Imaging Methods to Evaluate Non-Alcoholic Fatty Liver Disease with Fat Quantification: A Review.用于评估非酒精性脂肪性肝病并进行脂肪定量的非侵入性成像方法:综述
Diagnostics (Basel). 2023 May 25;13(11):1852. doi: 10.3390/diagnostics13111852.
9
The environmental pollutant, polychlorinated biphenyl 126, alters liver function in a rodent model of alcohol-associated liver disease.环境污染物多氯联苯 126 会改变酒精相关性肝病啮齿动物模型中的肝功能。
Alcohol Clin Exp Res (Hoboken). 2023 Jan;47(1):60-75. doi: 10.1111/acer.14976. Epub 2022 Dec 1.
10
Pathogenesis of Alcohol-Associated Liver Disease.酒精性肝病的发病机制
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1492-1513. doi: 10.1016/j.jceh.2022.05.004. Epub 2022 May 31.

本文引用的文献

1
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.抑制甘油三酯合成可改善非酒精性脂肪性肝炎肥胖小鼠的肝脂肪变性,但会加重肝损伤和肝纤维化。
Hepatology. 2007 Jun;45(6):1366-74. doi: 10.1002/hep.21655.
2
Control of peroxisome proliferator-activated receptor fate by the ubiquitinproteasome system.泛素蛋白酶体系统对过氧化物酶体增殖物激活受体命运的调控
J Recept Signal Transduct Res. 2006;26(5-6):679-92. doi: 10.1080/10799890600928202.
3
Alcohol and lipid metabolism.酒精与脂质代谢
J Gastroenterol Hepatol. 2006 Oct;21 Suppl 3:S56-60. doi: 10.1111/j.1440-1746.2006.04582.x.
4
Ethanol-induced liver injury: potential roles for egr-1.乙醇诱导的肝损伤:早期生长反应因子-1的潜在作用
Alcohol Clin Exp Res. 2005 Nov;29(11 Suppl):146S-150S. doi: 10.1097/01.alc.0000189286.81943.51.
5
Early growth response-1 transcription factor is essential for ethanol-induced fatty liver injury in mice.早期生长反应因子-1转录因子对小鼠乙醇诱导的脂肪肝损伤至关重要。
Gastroenterology. 2005 Jun;128(7):2066-76. doi: 10.1053/j.gastro.2005.02.065.
6
The role of AMP-activated protein kinase in the action of ethanol in the liver.AMP 激活的蛋白激酶在乙醇对肝脏作用中的角色。
Gastroenterology. 2004 Dec;127(6):1798-808. doi: 10.1053/j.gastro.2004.09.049.
7
Decreased proteasome activity is associated with increased severity of liver pathology and oxidative stress in experimental alcoholic liver disease.蛋白酶体活性降低与实验性酒精性肝病中肝脏病理严重程度增加及氧化应激相关。
Alcohol Clin Exp Res. 2004 Aug;28(8):1257-63. doi: 10.1097/01.alc.0000134233.89896.19.
8
Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver.酒精性肝病的最新进展II. 综述:酒精性脂肪肝的分子机制
Am J Physiol Gastrointest Liver Physiol. 2004 Jul;287(1):G1-6. doi: 10.1152/ajpgi.00056.2004.
9
A new approach to drug therapy in non-alcoholic steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)药物治疗的新方法。
J Int Med Res. 2003 Nov-Dec;31(6):537-51. doi: 10.1177/147323000303100610.
10
A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production.氧化应激在急性酒精诱导的肝脏肿瘤坏死因子-α生成中起关键作用。
Am J Pathol. 2003 Sep;163(3):1137-46. doi: 10.1016/s0002-9440(10)63473-6.